Impact of Saccharomyces cerevisiae DSM 34246 (Canobios-BL) var. boulardii Supplementation on Nutritional Status and Fecal Parameters in Healthy Breeding Adult Cats
Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Animals and Study Design
2.2. Method of Data Collection
2.3. Statistical Analysis Methods
- y = dependent variable;
- μ = overall mean;
- Si = fixed effect of the sex (i = F; M);
- G = fixed effect of the treatment (j = 0, 1);
- Tk = fixed effect of the kth time (k = 1, 6).
- GTjk = fixed effect of the interaction between the jth treatment and kth time;
- ejkn = error.
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Li, Y.; Ali, I.; Lei, Z.; Li, Y.; Yang, M.; Yang, C.; Li, L. Effect of a Multistrain Probiotic on Feline Gut Health Through the Fecal Microbiota and Its Metabolite SCFAs. Metabolites 2023, 13, 228. [Google Scholar] [CrossRef]
- Blake, A.B.; Suchodolski, J.S. Importance of gut microbiota for the health and disease of dogs and cats. Anim. Front. 2016, 6, 37–42. [Google Scholar] [CrossRef]
- Meineri, G.; Martello, E.; Atuahene, D.; Miretti, S.; Stefanon, B.; Sandri, M.; Biasato, I.; Corvaglia, M.R.; Ferrocino, I.; Cocolin, L.S. Effects of Saccharomyces boulardii Supplementation on Nutritional Status, Fecal Parameters, Microbiota, and Mycobiota in Breeding Adult Dogs. Vet. Sci. 2022, 9, 389. [Google Scholar] [CrossRef]
- Pais, P.; Almeida, V.; Yılmaz, M.; Teixeira, M.C. Saccharomyces boulardii: What Makes It Tick as Successful Probiotic? J. Fungi 2020, 6, 78. [Google Scholar] [CrossRef]
- Zhang, M.; Mo, R.; Li, M.; Qu, Y.; Wang, H.; Liu, T.; Liu, P.; Wu, Y. Comparison of the Effects of Enzymolysis Seaweed Powder and Saccharomyces boulardii on Intestinal Health and Microbiota Composition in Kittens. Metabolites 2023, 13, 637. [Google Scholar] [CrossRef]
- Kligler, B.; Cohrssen, A. Probiotics. Am. Fam. Physician 2008, 78, 1073–1078. [Google Scholar]
- McFarland, L.V. Common Organisms and Probiotics: Saccharomyces boulardii. In The Microbiota in Gastrointestinal Pathophysiology; Academic Press: Cambridge, MA, USA, 2017; pp. 145–164. [Google Scholar]
- Kelesidis, T.; Pothoulakis, C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap. Adv. Gastroenterol. 2012, 5, 111–125. [Google Scholar] [CrossRef]
- Maturana, M.; Castillejos, L.; Martin-Orue, S.M.; Minel, A.; Chetty, O.; Felix, A.P.; Adib Lesaux, A. Potential benefits of yeast Saccharomyces and their derivatives in dogs and cats: A review. Front. Vet. Sci. 2023, 10, 1279506. [Google Scholar] [CrossRef]
- D’Angelo, S.; Fracassi, F.; Bresciani, F.; Galuppi, R.; Diana, A.; Linta, N.; Bettini, G.; Morini, M.; Pietra, M. Effect of Saccharomyces boulardii in dog with chronic enteropathies: Double-blinded, placebo-controlled study. Vet. Rec. 2018, 182, 258. [Google Scholar] [CrossRef]
- EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP); Bampidis, V.; Azimonti, G.; Bastos, M.D.L.; Christensen, H.; Durjava, M.; Dusemund, B.; Kouba, M.; López-Alonso, M.; López Puente, S.; et al. Safety and efficacy of a feed additive consisting of Saccharomyces cerevisiae DSM 34246 (Canobios-BL) for cats and dogs (ACEL pharma s.r.l.). Scientific Opinion. EFSA J. 2024, 22, e8802. [Google Scholar]
- FEDIAF. Nutritional Guidelines for Complete and Complementary Pet Food for Cats and Dogs. 2019. Available online: https://europeanpetfood.org/ (accessed on 16 June 2020).
- Baldwin, K.; Bartges, J.; Buffington, T.; Freeman, L.M.; Grabow, M.; Legred, J.; Ostwald, D. AAHA nutritional assessment guidelines for dogs and cats. J. Am. Anim. Hosp. Assoc. 2010, 46, 285–296. [Google Scholar] [CrossRef]
- WSAVA. World Small Animal Veterinary Association Global Nutrition Committee (Body Condition Score); WSAVA: Rio de Janeiro, Brazil, 2013. [Google Scholar]
- Davies, G.J.; Crowder, M.; Reid, B.; Dickerson, J.W. Bowel function measurements of individuals with different eating patterns. Gut 1986, 27, 164–169. [Google Scholar] [CrossRef]
- Greco, D. Diagnosis and Dietary Management of Gastro-Intestinal Disease. Purina Vet Diets 2011. Available online: https://www.purinaveterinarydiets.com/clinic-support/clinicresources/for-your-clinic/diagnose-gi-problems-with-thequick-guide-referencetool/ (accessed on 15 November 2024).
- Lonigro, N.; Perondi, F.; Bruni, N.; Bigliati, M.; Costale, A.; Pagani, E.; Lippi, I.; Melocchi, A.; Zema, L.; Meineri, G.; et al. How does Saccharomyces cerevisiae DSM 34246 var. Boulardi supplementation impact the well-being of healthy adult dogs? Animals 2025, in press. [Google Scholar]
- Stercova, E.; Kumprechtova, D.; Auclair, E.; Novakova, J. Effects of live yeast dietary supplementation on nutrient digestibility and fecal micro ora in beagle dogs. J. Anim. Sci. 2016, 94, 2909–2918. [Google Scholar] [CrossRef]
- Santos, J.; Aquino, A.; Glória, M.; Avila-Campos, M.; Oba, P.; Santos, K. Effects of dietary yeast cell wall on faecal bacteria and fermentation products in adult cats. J. Anim. Physiol. Anim. Nutr. 2018, 102, 1091–1101. [Google Scholar] [CrossRef]
- Bruni, N.; Martello, E.; Fusi, E.; Meineri, G.; Giardini, A. Study of fecal parameters and body condition in dogs with a diet supplemented with Lactobacillus acidophilus D2/CSL (CECT 4529). Ital. J. Anim. Sci. 2020, 1, 704–711. [Google Scholar] [CrossRef]
- Grellet, A.; Mila, H.; Heilmann, R.M.; Feugier, A.; Gruetzner, N.; Suchodolski, J.S.; Steiner, J.M.; Chastant-Maillard, S. Effect of age, gestation and lactation on faecal IgA and calprotectin concentrations in dogs. J. Nutr. Sci. 2014, 3, 41. [Google Scholar] [CrossRef]
- Choi, Y.J.; Lee, S.R.; Oh, J.W. Effects of dietary fermented seaweed and seaweed fusiforme on growth performance, carcass parameters and immunoglobulin concentration in broiler chicks. Asian Australas J. Anim. Sci. 2014, 27, 862–870. [Google Scholar] [CrossRef]
- de Oliveira Matheus, L.F.; Risolia, L.W.; Ernandes, M.C.; de Souza, J.M.; Oba, P.M.; Vendramini, T.H.A.; Pedrinelli, V.; Henríquez, L.B.F.; de Oliveira Massoco, C.; Pontieri, C.F.F.; et al. Effects of Saccharomyces cerevisiae cell wall addition on feed digestibility, fecal fermentation and microbiota and immunological parameters in adult cats. BMC Vet Res. 2021, 17, 351. [Google Scholar] [CrossRef]
- Lima, L.M.; Silva, J.W., Jr.; Ogoshi, R.C.S.; dos Reis, J.S.; França, J.; Zangeronimo, M.G.; Saad, F.S.O.B. Evaluation of raw yeast extract (Saccharomyces cerevisiae) as an ingredient, additive or palatability agent in wet diet for cats. Int. J. Biol. 2015, 8, 1. [Google Scholar] [CrossRef]
- Middelbos, I.S.; Godoy, M.R.; Fastinger, N.D.; Fahey, G.C. A dose-response evaluation of spray-dried yeast cell wall supplementation of diets fed to adult dogs: Effects on nutrient digestibility, immune indices, and fecal microbial populations. J. Anim. Sci. 2007, 85, 3022–3032. [Google Scholar] [CrossRef] [PubMed]
t0 | t1 | t2 | t3 | t4 | t5 | Average | p-Value | |
---|---|---|---|---|---|---|---|---|
BW (Kg ± SE) | ||||||||
CTR | 3.9 ± 0.1 | 4.0 ± 0.1 | 4.0 ± 0.1 | 4.0 ± 0.1 | 4.0 ± 0.2 | 4.1 ± 0.2 | 4.0 ± 0.1 | 1.00 |
SACC | 4.1 ± 0.1 | 4.1 ± 0.1 | 4.1 ± 0.1 | 4.1 ± 0.1 | 4.2 ± 0.1 | 4.2 ± 0.1 | 4.1 ± 0.1 | 1.00 |
BCS (score ± SE) | ||||||||
CTR | 5.9 ± 0.2 | 5.5 ± 0.3 | 5.9 ± 0.2 | 5.6 ± 0.3 | 5.7 ± 0.4 | 5.6 ± 0.3 | 5.7 ± 0.1 | 0.86 |
SACC | 5.8 ± 0.3 | 5.3 ± 0.4 | 4.7 ± 0.2 | 4.4 ± 0.1 | 4.2 ± 0.1 | 4.1 ± 0.1 | 4.7 ± 0.1 | <0.0001 |
t0 | t1 | t2 | t3 | t4 | t5 | Average | p-Value | |
---|---|---|---|---|---|---|---|---|
FS (score ± SE) | ||||||||
CTR | 4.4 ± 0.5 | 4.1 ± 0.1 | 4.1 ± 0.1 | 4.3 ± 0.2 | 4.3 ± 0.2 | 4.6 ± 0.3 | 4.3 ± 0.1 | 0.85 |
SACC | 4.3 ± 0.4 | 4.3 ± 0.4 | 3.1 ± 0.1 | 3.3 ± 0.2 | 3.1 ± 0.1 | 3.0 ± 0.0 | 3.5 ± 0.1 | 0.0006 |
FSp (score ± SE) | ||||||||
CTR | 4.5 ± 0.5 | 4.4 ± 0.2 | 4.5 ± 0.2 | 4.4 ± 0.3 | 4.4 ± 0.2 | 4.6 ± 0.3 | 4.5 ± 0.1 | 1.00 |
SACC | 4.4 ± 0.4 | 4.3 ± 0.4 | 3.2 ± 0.2 | 3.1 ± 0.2 | 3.0 ± 0.1 | 2.7 ± 0.1 | 3.4 ± 0.1 | 0.0001 |
DM (% ± SE) | ||||||||
CTR | 31.0 ± 5.7 | 33.0 ± 1.9 | 31.6 ± 1.8 | 34.4 ± 2.6 | 36.5 ± 3.4 | 32.7 ± 3.9 | 33.2 ± 1.4 | 0.89 |
SACC | 32.4 ± 4.3 | 33.6 ± 3.7 | 51.9 ± 3.9 | 49.9 ± 1.5 | 52.1 ± 2.2 | 58.0 ± 2.8 | 46.3 ± 2.0 | <0.0001 |
UM (% ± SE) | ||||||||
CTR | 68.6 ± 5.7 | 66.0 ± 1.8 | 67.2 ± 2.0 | 64.5 ± 2.4 | 62.7 ± 3.3 | 66.1 ± 3.8 | 65.8 ± 1.4 | 0.87 |
SACC | 67.3 ± 4.4 | 65.6 ± 3.7 | 46.9 ± 3.8 | 48.8 ± 1.5 | 47.1 ± 2.1 | 41.2 ± 2.9 | 52.9 ± 2.0 | <0.0001 |
IgA (mg/g ± SE) | ||||||||
CTR | 5.4 ± 0.3 | 5.9 ± 0.2 | 5.8 ± 0.2 | 5.6 ± 0.2 | 5.8 ± 0.2 | 5.5 ± 0.1 | 5.7 ± 0.1 | 0.64 |
SACC | 5.8 ± 0.2 | 5.5 ± 0.2 | 5.6 ± 0.2 | 5.9 ± 0.2 | 6.1 ± 0.2 | 6.6 ± 0.2 | 5.9 ± 0.1 | 0.0084 |
Group | t0 | t1 | t2 | t3 | t4 | t5 | Average | p-Value |
---|---|---|---|---|---|---|---|---|
CTR | 0.20 ± 0.01 | 0.18 ±0.01 | 0.20 ± 0.01 | 0.19 ± 0.01 | 0.20 ± 0.01 | 0.20 ± 0.01 | 0.20 ± 0.00 | 0.46 |
SACC | 0.19 ± 0.01 | 0.18 ± 0.01 | 0.20 ± 0.01 | 0.20 ± 0.01 | 0.20 ± 0.01 | 0.21 ± 0.01 | 0.20 ± 0.00 | 0.60 |
t0 | t1 | t2 | t3 | t4 | t5 | Average | p-Value | |
---|---|---|---|---|---|---|---|---|
FI (g ± SE) | ||||||||
CTR | - | 330.0 ± 1.0 | 329.4 ± 0.8 | 329.2 ± 0.8 | 328.9 ± 0.6 | 329.4 ± 1.0 | 329.4 ± 0.4 | 0.92 |
SACC | - | 329.6 ± 0.8 | 329.8 ± 0.8 | 328.6 ± 0.6 | 330.3 ± 0.6 | 329.2 ± 1.0 | 329.5 ± 0.4 | 0.60 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lonigro, N.; Martello, E.; Bruni, N.; Bigliati, M.; Costale, A.; Lippi, I.; Meineri, G.; Perondi, F. Impact of Saccharomyces cerevisiae DSM 34246 (Canobios-BL) var. boulardii Supplementation on Nutritional Status and Fecal Parameters in Healthy Breeding Adult Cats. Vet. Sci. 2025, 12, 44. https://doi.org/10.3390/vetsci12010044
Lonigro N, Martello E, Bruni N, Bigliati M, Costale A, Lippi I, Meineri G, Perondi F. Impact of Saccharomyces cerevisiae DSM 34246 (Canobios-BL) var. boulardii Supplementation on Nutritional Status and Fecal Parameters in Healthy Breeding Adult Cats. Veterinary Sciences. 2025; 12(1):44. https://doi.org/10.3390/vetsci12010044
Chicago/Turabian StyleLonigro, Nicolò, Elisa Martello, Natascia Bruni, Mauro Bigliati, Annalisa Costale, Ilaria Lippi, Giorgia Meineri, and Francesca Perondi. 2025. "Impact of Saccharomyces cerevisiae DSM 34246 (Canobios-BL) var. boulardii Supplementation on Nutritional Status and Fecal Parameters in Healthy Breeding Adult Cats" Veterinary Sciences 12, no. 1: 44. https://doi.org/10.3390/vetsci12010044
APA StyleLonigro, N., Martello, E., Bruni, N., Bigliati, M., Costale, A., Lippi, I., Meineri, G., & Perondi, F. (2025). Impact of Saccharomyces cerevisiae DSM 34246 (Canobios-BL) var. boulardii Supplementation on Nutritional Status and Fecal Parameters in Healthy Breeding Adult Cats. Veterinary Sciences, 12(1), 44. https://doi.org/10.3390/vetsci12010044